Inbiopro We are an Indian biopharmaceutical company with a focus on biosimilar co-development with manufacturing & marketing partners. Our in-house research towards immediate IP development is in the areas of purification methods for recombinant proteins, new high expression stable cell lines (looking beyond CHO) and protein modification techniques. Inbiopro’s initial portfolio of products for co-development includes many of the E.coli based recombinant biosimilars as well as platform for CHO cell expressing MAbs.